内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Kemble George. Insider active across 1 company, notably Sagimet Biosciences Inc.. Cumulatively, 12 disclosures have been logged. Split: 0 buy · 6 sells. Total volume traded: €3.8m. History available since 7 September 2023. The latest transaction was disclosed on 14 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kemble George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
24,369 股@ US$6.360.024% mcap2.3% 占其流量Series A Common StockSEC:0001193125-26-354018:1
326,618 股@ US$6.360.32% mcap30.9% 占其流量Series A Common StockSEC:0001193125-26-354018:0
350,987 股@ US$10.23280.55% mcap53.5% 占其流量Series A Common StockSEC:0001193125-26-354018:2
9,751 股@ US$6.360.010% mcap6.9% 占其流量Series A Common StockSEC:0001193125-26-347407:0
10,455 股@ US$6.360.011% mcap7.5% 占其流量Series A Common StockSEC:0001193125-26-347407:1
20,206 股@ US$9.95480.034% mcap22.5% 占其流量Series A Common StockSEC:0001193125-26-347407:2
18,844 股@ US$7.45750.029% mcap25.2% 占其流量Series A Common StockSEC:0001193125-26-312386:0
37,688 股@ US$7.694269.0% 占其流量Series A Common StockSEC:0001104659-25-115071:0
23,625 股@ US$3.167461.0% 占其流量Series A Common StockSEC:0001104659-24-082630:0
14,062 股@ US$3.100935.4% 占其流量Series A Common StockSEC:0001104659-24-081887:0
150,750 股0Series A Common StockSEC:0001104659-23-120374:0
5,630 股@ US$0.793.7% 占其流量Series A Common StockSEC:0001104659-23-099310:0
About Kemble George
Kemble George is a declarant and a director of Sagimet Biosciences Inc. (XNAS). He has filed 9 filings in total, and across the 9 sampled recent filings from 2023-09-08 to 2026-08-12, sales total 657226 EUR and the modal transaction nature is Cession.